We have isolated three types of cDNAs encoding novel 1,3-N-acetylglucosaminyltransferases (designated 3Gn-T2, -T3, and -T4) from human gastric mucosa and the neuroblastoma cell line SK-N-MC. These enzymes are predicted to be type 2 transmembrane proteins of 397, 372, and 378 amino acids, respectively. They share motifs conserved among members of the 1,3-galactosyltransferase family and a 1,3-N-acetylglucosaminyltransferase (designated 3Gn-T1), but show no structural similarity to another type of 1,3-N-acetylglucosaminyltransferase (iGnT). Each of the enzymes expressed by insect cells as a secreted protein fused to the FLAG peptide showed 1,3-N-acetylglucosaminyltransferase activity for type 2 oligosaccharides but not 1,3-galactosyltransferase activity. These enzymes exhibited different substrate specificity. Transfection of Namalwa KJM-1 cells with 3Gn-T2, -T3, or -T4 cDNA led to an increase in poly-N-acetyllactosamines recognized by an anti-i-antigen antibody or specific lectins. The expression profiles of these 3Gn-Ts were different among 35 human tissues. 3Gn-T2 was ubiquitously expressed, whereas expression of 3Gn-T3 and -T4 was relatively restricted. 3Gn-T3 was expressed in colon, jejunum, stomach, esophagus, placenta, and trachea. 3Gn-T4 was mainly expressed in brain. These results have revealed that several 1,3-Nacetylglucosaminyltransferases form a family with structural similarity to the 1,3-galactosyltransferase family. Considering the differences in substrate specificity and distribution, each 1,3-N-acetylglucosaminyltransferase may play different roles.A family of human 1,3-galactosyltransferases (3Gal-Ts) 1 consisting of five members (3Gal-T1, -T2, -T3, -T4, and -T5) was recently identified (1-4). The first 1,3-galactosyltransferase (3Gal-T1), which catalyzes the formation of type 1 oligosaccharides, was isolated by us using an expression cloning approach (1). Expression patterns of 3Gal-T1 and type 1 oligosaccharides strongly suggested the existence of 3Gal-T1 homologs. For instance, type 1-derived oligosaccharides such as sialyl-Le a were known to be expressed in colon and pancreatic cancer cell lines, whereas expression of 3Gal-T1 was detected in brain, but not in cancer cells. Our early approach using Southern hybridization failed to detect the existence of 3Gal-T1 homologous genes. However, recent accumulation of nucleotide sequence information on human cDNAs and genes such as expressed sequence tags (ESTs) enabled us to search homologous genes that do not have high similarity as detected by hybridization, but show significant similarity. A homology search based on the nucleotide or amino acid sequence of 3Gal-T1 led to the isolation of 3Gal-T2, -T3, and -T4, indicating that 3Gal-Ts form a family (1-3).3Gal-T2 catalyzed a similar reaction, but showed different substrate specificity compared with 3Gal-T1. The activity of 3Gal-T3 has not been detected, whereas the corresponding mouse enzyme exhibits weak 3Gal-T activity for both GlcNAc and GalNAc (5). On the other...